'India will play a vital role in global clinical research market'
Healthcare Radius|April 2023
With the need for rapid rollout of new drugs, the clinical trials segment has seen several new trends such as technology adoption, decentralized trials, and so on. In an interview to Nagesh Joshi, Krutikesh Age, Co-founder, DPHS elaborates the latest trends in this space and how the segment will look like in the near future. Excerpts of the interview:
Krutikesh Age
'India will play a vital role in global clinical research market'

Q. What are the trends in India's clinical trials market?

The regulatory authorities have become stringent in enforcing safety and ethical standards in clinical trials. Sponsors and CROS are now investing more in quality control measures to ensure compliance with these standards. Digital technologies such as electronic data capture (EDC), e-consent, and telemedicine are being increasingly used in clinical trials in India. These technologies not only improve data accuracy and patient safety but also reduce costs and increase efficiency.

The COVID-19 pandemic has accelerated the adoption of decentralized trials in India. Sponsors and CROS are exploring innovative ways to conduct trials remotely, such as home-based monitoring and virtual site visits. There also is a growing trend towards the emergence of niche CROs in India that specialize in specific therapeutic areas. These CROS have knowledge and expertise in their respective areas and they aim at provide better value to sponsors.

Collaboration between academia, industry, and government is growing in India. There is a focus on developing strategic partnerships to drive innovation and bring new drugs to the market faster.

There is a growing focus on patient centricity. Companies are involving patients in the design of their trials, seeking feedback to ensure that their trials are conducted in a patient-friendly manner.

Q. What has been the impact of Covid-19?

The COVID-19 pandemic has had a significant impact on the clinical trials scenario in India. The pandemic has disrupted the conduct of clinical trials globally, including in India. Due to lockdowns and restrictions on travel, many clinical trial sites were temporarily closed, resulting in delays in ongoing trials.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM HEALTHCARE RADIUSView all
KIMSHEALTH launches electrophysiology lab with 3D mapping
Healthcare Radius

KIMSHEALTH launches electrophysiology lab with 3D mapping

'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.

time-read
1 min  |
November 2024
Molbio boosts Goa's healthcare system with CSR initiatives
Healthcare Radius

Molbio boosts Goa's healthcare system with CSR initiatives

The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies

time-read
1 min  |
November 2024
USV introduces affordable heart failure medication
Healthcare Radius

USV introduces affordable heart failure medication

This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.

time-read
1 min  |
November 2024
City Imaging & Clinical Labs to expand services to 50 hospitals
Healthcare Radius

City Imaging & Clinical Labs to expand services to 50 hospitals

The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.

time-read
1 min  |
November 2024
Oncare raises $1 million in seed funding, to set up 10 units
Healthcare Radius

Oncare raises $1 million in seed funding, to set up 10 units

Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.

time-read
1 min  |
November 2024
Nutrabay forays into Ayurvedic supplements market with Shilajit
Healthcare Radius

Nutrabay forays into Ayurvedic supplements market with Shilajit

Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.

time-read
1 min  |
November 2024
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
Healthcare Radius

INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY

The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.

time-read
8 mins  |
November 2024
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Healthcare Radius

TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES

Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.

time-read
3 mins  |
November 2024
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
Healthcare Radius

BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY

As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.

time-read
8 mins  |
November 2024
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
Healthcare Radius

LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION

In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?

time-read
3 mins  |
November 2024